Role of Community Pharmacist in Management of Anaemia
[1]
Somarouthu Venkata Saibaba, Department of Pharmacy Practice, KVK College of Pharmacy, Hyderabad, Telangana.
[2]
Bandameedi Ramu, Department of Pharmacy Practice, KVK College of Pharmacy, Hyderabad, Telangana.
Anaemia is a condition in which number of RBC cells are decreased or oxygen carrying capacity of blood is reduced, i.e enough haemoglobin is not available to carry sufficient oxygen from the lungs to supply the needs of the tissues. Iron is an important essential element for almost all living organisms in various metabolic processes, including oxygen transport, synthesis of deoxyribonucleic acid (DNA), electron transport etc. Haematinics are the drugs which are commonly prescribed in the initial treatment of anaemia and also given during pregnancy and lactation phase. Various types of oral iron preparations (Tablets, syrups, capsules) are available in the market as single or fixed dose combination with other minerals, micronutrients etc. Bioavailability of oral iron preparations depends upon the type of dosage form, its dose, age, sex, food and liquids that are taken along with the iron supplements. Presence of minerals or vitamins in combination also influence the absorption of iron. The main objective of present paper is to elaborate the role of pharmacist in improving bioavailability of haematinics by educating the consumer in selecting right dosage form, right combination and right strength.
Anaemia, Iron Supplements, Microcytic Anaemia, Community Pharmacist
[1]
Harsh mohan, Text book of pathology, 5th edition, jaypee publications 2005, 355-441
[2]
Hunt J. R, Am. J. clin. Nutr. 2003, 78: 633S-639S.
[3]
Ines e, Hurrell R. Am. J. clin. Nutr. 2010, 9: 1461S-7S.
[4]
Karelia B. N, Buch J. G, J. Pharmacol, Pharmacother. 2012, 3: 35-38.
[5]
19th WHO model list of Essential Medicines, Apr. 2015.
[6]
Santiago P, The scientific world journal 2011, 10: 1-5.
[7]
Heinrich HC Arzneimittlforschung 1975, 25: 420-426.
[8]
Harington M, Holz C, Zeder C, Eur. J. Clin. Nutr. 2011, 65: 20-25.
[9]
Gomes da Costa, A.; Vargas, S.; Clode, N.; Graça, L. M. Prevalence and risk factors for iron deficiency anemia and iron depletion during pregnancy: A prospective study. Acta Med. Port. 2016, 29, 514–518.
[10]
Sharma, P.; Mehta, S.; Nagar, R. Prevalence of anemia and socio-demographic factors associated with anemia among pregnant women attending antenatal Hospital in Jaipur City, India. IOSR J. Pharm. Biol. Sci. 2013, 6, 1–5.
[11]
Bentley, M. E.; Griffiths, P. L. The burden of anemia among women in India. Eur. J. Clin. Nutr. 2003, 57, 52–60.
[12]
World Health Organization (WHO). Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity; World Health Organization: Geneva, Switzerland, 2011.
[13]
Wang, Q. M.; Zhang, S. K.; Hu, M.; Kang, X. X. Establishment of quality assurance system of the National Free Preconception Health Examination Project in China. Chin. Med. J. 2015, 95, 166–168.
[14]
Le, C. H. H. The prevalence of anemia and moderate-severe anemia in the US population (NHANES 2003–2012). PLoS ONE 2016, 11, e0166635.
[15]
Behboudi-Gandevani, S.; Imani, S.; Moghaddam-Banaem, L.; Roudbar-Mohammadi, S. Can intrauterine contraceptive devices lead to VulvoVaginal Candidiasis (VVC) and Anemia in Iranian new users? Sex. Reprod. Healthc. 2015, 6, 40–43.
[16]
National Health and Family Planning Commission of the PRC. Report of investigation on the contraception effect of intrauterine device by one hundred and twenty thousand cases. Chin. J. Family Plan. 2007, 15, 132–136.
[17]
Borghei, A.; Qorbani, M.; Borghei, N. S.; Kazeminejad, V.; Seifi, F. Effects of IUD on iron status in IUD users in Gorgan, Iran. Med. J. Islam. Repub. Iran 2011, 25, 131–135.
[18]
Blanco-Rojo, R.; Toxqui, L.; Lopez-Parra, A. M.; Arroyo-Pardo, E.; Vaquero, M. P. Influence of diet, menstruation and genetic factors on iron status: A cross-sectional study in Spanish women of childbearing age. Int. J. Mol. Sci. 2014, 15, 4077–4087.
[19]
World Health Organization (WHO). The Global Prevalence of Anaemia in 2011; World Health Organization: Geneva, Switzerland, 2015.
[20]
Adamu, A. L.; Crampin, A.; Kayuni, N.; Amberbir, A.; Koole, O.; Phiri, A.; Nyirenda, M.; Fine, P. Prevalence and risk factors for anemia severity and type in Malawian men and women: Urban and rural differences. Popul. Health Metr. 2017, 15, 12.
